D-Wave Quantum Inc.

Based on a comprehensive review of QBTS, the analysis strongly advises against purchasing the stock at this time.

Technical Analysis: The stock is in a severe and prolonged downtrend, trading near its 52-week low after a -61% drawdown. While it may be technically oversold, there is no clear signal of a positive momentum reversal.

Fundamentals & Valuation: The core issue is operational unprofitability, with significant losses despite a decent gross margin. Key efficiency metrics are very weak, and traditional valuation ratios are negative, suggesting the stock is overvalued relative to its current earnings power.

Risk Assessment: High volatility and major unanswered questions about the path to profitability make this an exceptionally speculative investment. The financials do not yet support a sustainable business model.

Recommendation: DO NOT BUY. QBTS represents a high-risk proposition with weak fundamentals and negative momentum. Investors should wait for clear, sustained improvements in profitability and operational efficiency before considering a position. The current financial performance does not justify the investment risk.

RockFlow Model Forecast: Three Scenarios for 2026

Based on the provided analysis, the 12-month outlook for QBTS is highly challenging. The primary catalyst for a positive turnaround would be a clear and credible demonstration of a path to profitability, such as a significant reduction in operational losses or a major new contract that fundamentally improves its financial outlook. However, the risks are substantial, dominated by the ongoing operational unprofitability, weak efficiency metrics, and the absence of a confirmed sustainable business model.

Given the severe downtrend and negative fundamentals, the stock faces a high risk of continued volatility and potential further declines if the company fails to address its core financial weaknesses. With no analyst target price available, the recommendation is to avoid the stock. Investors should only reconsider if subsequent quarterly reports show concrete, sustained evidence of a turnaround in both profitability and operational efficiency.

Wall Street Consensus

Most Wall Street analysts are optimistic about D-Wave Quantum Inc.'s 12-month outlook, with consensus target around $18.78, indicating expected upside potential.

Overall, QBTS has investment potential but also faces challenges. Here are key factors to weigh before investing.

Of course. Here is the technical analysis of QBTS's price performance.

Overall Assessment QBTS has experienced severe and protracted negative price action, dramatically underperforming the broader market over the past year, as evidenced by a maximum drawdown of over -61%.

Short-term Performance The stock's performance remains deeply negative in the short term, with a staggering 1-month decline of -28.07% and a 3-month drop of -12.0%. While the trailing 3-month relative strength figure of -15.9% suggests the stock has actually outperformed its benchmark during this recent period, this is a relative measure against an even steeper market decline and does not negate the significant absolute losses incurred by shareholders.

Current Position With a current price of $17.96, QBTS trades significantly closer to its 52-week low of $4.45 than its high of $46.75, placing it in the lower quartile of its yearly range. Given the precipitous price drop and its high beta indicating substantial volatility, the stock is in an technically oversold condition, though this does not inherently signal an imminent reversal without a change in underlying momentum.

Revenue & Profitability: QBTS demonstrates concerning profitability trends with significant operating losses (-$34.8M in Q4) despite maintaining a healthy gross margin of 64.8%. The company's net income ratio worsened to -15.4% in Q4 from -37.4% in Q3, primarily due to substantial R&D and SG&A expenses outweighing modest revenue of $2.75 million. While quarterly revenue declined sequentially, the improved loss ratio suggests some cost management progress.

Financial Health: The company maintains exceptionally strong liquidity with current and quick ratios above 42, supported by a cash ratio of 30.0. However, QBTS shows weak cash flow generation with negative operating cash flow per share (-$0.052) and a concerning cash flow to debt ratio of -2.41. The minimal debt ratio of 0.83% indicates low leverage, but negative interest coverage of -10.3 highlights earnings insufficiency to service existing obligations.

Operational Efficiency: QBTS exhibits poor operational metrics with negative returns on assets (-4.6%) and equity (-5.0%), reflecting inefficient capital utilization. The asset turnover of 0.003 indicates minimal revenue generation from the asset base, while the lengthy cash conversion cycle of 222 days suggests working capital management challenges. Inventory turnover of 0.35 and receivables turnover of 1.73 further underscore operational inefficiencies across the business cycle.

1. Valuation Level

QBTS's valuation presents significant challenges due to negative trailing and forward P/E ratios (-12.48 and -54.51, respectively). These negative values indicate the company is currently generating a net loss, making the P/E ratio an ineffective metric for traditional valuation assessment. The negative EV/EBITDA of -224.77 further confirms substantial negative earnings, strongly suggesting the stock is overvalued based on current profitability metrics.

2. Peer Comparison

A comparative analysis is hindered as specific industry average data is unavailable. However, QBTS's Price-to-Book (P/B) ratio of 11.11 is extremely high, typically indicating the market price is significantly above the company's net asset value. While the forward PEG ratio of 0.77 suggests potential undervaluation relative to expected earnings growth, this metric must be viewed with extreme caution due to the deeply negative earnings baseline, making a reliable peer comparison impossible without industry benchmarks.

Volatility Risk: QBTS exhibits high volatility risk, evidenced by its beta of 1.55, indicating it is significantly more volatile than the broader market. This elevated risk is further confirmed by the substantial 1-year maximum drawdown of -61.57%, highlighting the potential for severe capital depreciation during market downturns.

Other Risks: While the absence of reported short interest suggests limited speculative pressure from bearish bets, this does not eliminate other significant vulnerabilities. The lack of short interest data warrants confirmation of reporting applicability and raises questions about the stock's overall liquidity and investor sentiment.